Contemporary Statistics of Acute Ischemic Stroke and Transient Ischemic Attack in 2021: Insights From the CRCS-K-NIH Registry
- Author:
Do Yeon KIM
1
;
Tai Hwan PARK
;
Yong-Jin CHO
;
Jong-Moo PARK
;
Kyungbok LEE
;
Minwoo LEE
;
Juneyoung LEE
;
Sang Yoon BAE
;
Da Young HONG
;
Hannah JUNG
;
Eunvin KO
;
Hyung Seok GUK
;
Beom Joon KIM
;
Jun Yup KIM
;
Jihoon KANG
;
Moon-Ku HAN
;
Sang-Soon PARK
;
Keun-Sik HONG
;
Hong-Kyun PARK
;
Jeong-Yoon LEE
;
Byung-Chul LEE
;
Kyung-Ho YU
;
Mi Sun OH
;
Dong-Eog KIM
;
Dong-Seok GWAK
;
Soo Joo LEE
;
Jae Guk KIM
;
Jun LEE
;
Doo Hyuk KWON
;
Jae-Kwan CHA
;
Dae-Hyun KIM
;
Joon-Tae KIM
;
Kang-Ho CHOI
;
Hyunsoo KIM
;
Jay Chol CHOI
;
Joong-Goo KIM
;
Chul-Hoo KANG
;
Sung-il SOHN
;
Jeong-Ho HONG
;
Hyungjong PARK
;
Sang-Hwa LEE
;
Chulho KIM
;
Dong-Ick SHIN
;
Kyu Sun YUM
;
Kyusik KANG
;
Kwang-Yeol PARK
;
Hae-Bong JEONG
;
Chan-Young PARK
;
Keon-Joo LEE
;
Jee Hyun KWON
;
Wook-Joo KIM
;
Ji Sung LEE
;
Hee-Joon BAE
;
Author Information
- Publication Type:Special Article
- From:Journal of Korean Medical Science 2024;39(34):e278-
- CountryRepublic of Korea
- Language:English
- Abstract: This report presents the latest statistics on the stroke population in South Korea, sourced from the Clinical Research Collaborations for Stroke in Korea-National Institute for Health (CRCS-K-NIH), a comprehensive, nationwide, multicenter stroke registry. The Korean cohort, unlike western populations, shows a male-to-female ratio of 1.5, attributed to lower risk factors in Korean women. The average ages for men and women are 67 and 73 years, respectively.Hypertension is the most common risk factor (67%), consistent with global trends, but there is a higher prevalence of diabetes (35%) and smoking (21%). The prevalence of atrial fibrillation (19%) is lower than in western populations, suggesting effective prevention strategies in the general population. A high incidence of large artery atherosclerosis (38%) is observed, likely due to prevalent intracranial arterial disease in East Asians and advanced imaging techniques.There has been a decrease in intravenous thrombolysis rates, from 12% in 2017–2019 to 10% in 2021, with no improvements in door-to-needle and door-to-puncture times, worsened by the coronavirus disease 2019 pandemic. While the use of aspirin plus clopidogrel for noncardioembolic stroke and direct oral anticoagulants for atrial fibrillation is well-established, the application of direct oral anticoagulants for non-atrial fibrillation cardioembolic strokes in the acute phase requires further research. The incidence of early neurological deterioration (13%) and the cumulative incidence of recurrent stroke at 3 months (3%) align with global figures. Favorable outcomes at 3 months (63%) are comparable internationally, yet the lack of improvement in dependency at 3 months highlights the need for advancements in acute stroke care.
